In summary, the QEP improves IDD by modulating targets such as Wnt5A, CTNNB1, IL-1β, MAPK14, MMP9, and MMP3 and by regulating the Wnt signaling and MAPK/MMP pathways. This evidence concerns the gene IL1B and intervertebral disk degenerative disorder.